Moderna - Stock Price History | MRNA

Historical daily share price chart and data for Moderna since 2023 adjusted for splits. The latest closing stock price for Moderna as of January 31, 2023 is 176.06.
  • The all-time high Moderna stock closing price was 484.47 on August 09, 2021.
  • The Moderna 52-week high stock price is 217.25, which is 23.4% above the current share price.
  • The Moderna 52-week low stock price is 115.03, which is 34.7% below the current share price.
  • The average Moderna stock price for the last 52 weeks is 156.15.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Moderna Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2022 156.6229 235.0500 235.0500 117.1300 179.6200 -29.28%
2021 247.6753 111.7300 484.4700 109.1800 253.9800 143.11%
2020 62.5042 19.2300 169.8600 17.7800 104.4700 434.10%
2019 18.1192 15.3300 28.3400 12.2600 19.5600 28.09%
2018 16.4338 18.6000 18.8000 13.5200 15.2700 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $67.639B $18.471B
Moderna, Inc. is a clinical-stage pharmaceutical company, primarily focused on discovering and developing messenger RNA (mRNA) based therapies. The company's mRNA based COVID-19 vaccine, Spikevax (mRNA-1273), is approved for use in adults in the United States. The vaccine is also authorized for emergency use in several countries as COVID-19 vaccine. The company has also developed booster doses of its COVID-19 vaccine and is developing variant-specific booster candidates.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $154.466B 9.42
GSK (GSK) United Kingdom $72.181B 8.99
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.127B 18.99
Ginkgo Bioworks Holdings (DNA) United States $3.783B 0.00
Myovant Sciences (MYOV) United Kingdom $2.614B 0.00
Arcus Biosciences (RCUS) United States $1.566B 23.51
Biohaven (BHVN) United States $1.301B 0.00
Emergent Biosolutions (EBS) United States $0.658B 5.17
ADC Therapeutics SA (ADCT) Switzerland $0.393B 0.00
Ambrx Biopharma (AMAM) United States $0.073B 0.00
Enzo Biochem (ENZ) United States $0.065B 0.00
SQZ Biotechnologies (SQZ) United States $0.024B 0.00
Gelesis Holdings (GLS) United States $0.022B 0.00